Bismuth Subsalicylate
Product Images NDC 70166-059

1 FDA label image from Lohxa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bismuth Subsalicylate (NDC 70166-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lohxa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display (Bismuthcup 20191219 210715)

Principal Display (Bismuthcup 20191219 210715)
Label for Bismuth Subsalicylate oral suspension by Lohxa, containing 262 mg per 15 mL. The label includes instructions to shake well before use, storage conditions at controlled room temperature (20 to 25°C), and mentions institutional use. The label also shows a barcode, lot and expiration placeholders, and Lohxa contact information in Worcester, MA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.